Epigenetics

Syndicate content
Google News
Updated: 12 hours 43 min ago

Goodman caps 48-year career with excellence award - MSUToday

Wed, 2019-03-06 14:29
Goodman caps 48-year career with excellence award  MSUToday

Jay Goodman, professor of pharmacology and toxicology, has been selected to receive the 2019 Pharmaceutical Research and Manufacturers of America ...

Constellation Pharmaceuticals to Present at Upcoming Investor Conference - Associated Press

Wed, 2019-03-06 14:17
Constellation Pharmaceuticals to Present at Upcoming Investor Conference  Associated Press

This *content* is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation.

Mechanism through which bacteria attack white blood cells - Science Daily

Wed, 2019-03-06 14:16
Mechanism through which bacteria attack white blood cells  Science Daily

A research team has discovered a mechanism with which bacteria activate white blood cells and attack an organism's immune system.

Constellation Pharmaceuticals to Present at Upcoming Investor Conference - Nasdaq

Wed, 2019-03-06 12:35
Constellation Pharmaceuticals to Present at Upcoming Investor Conference  Nasdaq

CAMBRIDGE, Mass., March 06, 2019-- Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in.

Belgian Nanoelectronics Firm Imec Developing Solid State Nanopore Technology for DNA Analysis - GenomeWeb

Wed, 2019-03-06 10:40
Belgian Nanoelectronics Firm Imec Developing Solid State Nanopore Technology for DNA Analysis  GenomeWeb

SAN FRANCISCO (GenomeWeb) – Imec, a nanoelectronics and digital technology company based in Belgium, is harnessing its expertise in semiconductor ...

Epigenetics Drugs Market Overview, New Opportunities & SWOT Analysis by 2025 - TheTokenClock

Wed, 2019-03-06 09:10
Epigenetics Drugs Market Overview, New Opportunities & SWOT Analysis by 2025  TheTokenClock

Advance Market Analytics published a new research publication on “Global Epigenetics Drugs Market Insights, to 2025” with 189 pages and enriched with ...

Epizyme As A Strategic Acquisition For Epigenetic Therapies - Seeking Alpha

Wed, 2019-03-06 08:01
Epizyme As A Strategic Acquisition For Epigenetic Therapies  Seeking Alpha

Epigenetics is a new therapeutic area with strategic implications.Epizyme's stock price has recovered following announced timeline for NDAs.Short-term ...

Epizyme As A Strategic Acquisition For Epigenetic Therapies - Seeking Alpha

Wed, 2019-03-06 08:00
Epizyme As A Strategic Acquisition For Epigenetic Therapies  Seeking Alpha

Epigenetics is a new therapeutic area with strategic implications. Epizyme's stock price has recovered following announced timeline for NDAs. Short-term ...

Epizyme As A Strategic Acquisition For Epigenetic Therapies - Seeking Alpha

Wed, 2019-03-06 08:00
Epizyme As A Strategic Acquisition For Epigenetic Therapies  Seeking Alpha

Epigenetics is a new therapeutic area with strategic implications. Epizyme's stock price has recovered following announced timeline for NDAs. Short-term ...

Epizyme As A Strategic Acquisition For Epigenetic Therapies - Seeking Alpha

Wed, 2019-03-06 08:00
Epizyme As A Strategic Acquisition For Epigenetic Therapies  Seeking Alpha

Epigenetics is a new therapeutic area with strategic implications. Epizyme's stock price has recovered following announced timeline for NDAs. Short-term ...

Epizyme As A Strategic Acquisition For Epigenetic Therapies - Seeking Alpha

Wed, 2019-03-06 08:00
Epizyme As A Strategic Acquisition For Epigenetic Therapies  Seeking Alpha

Epigenetics is a new therapeutic area with strategic implications. Epizyme's stock price has recovered following announced timeline for NDAs. Short-term ...

Epizyme As A Strategic Acquisition For Epigenetic Therapies - Seeking Alpha

Wed, 2019-03-06 08:00
Epizyme As A Strategic Acquisition For Epigenetic Therapies  Seeking Alpha

Epigenetics is a new therapeutic area with strategic implications. Epizyme's stock price has recovered following announced timeline for NDAs. Short-term ...

Epizyme As A Strategic Acquisition For Epigenetic Therapies - Seeking Alpha

Wed, 2019-03-06 08:00
Epizyme As A Strategic Acquisition For Epigenetic Therapies  Seeking Alpha

Epigenetics is a new therapeutic area with strategic implications. Epizyme's stock price has recovered following announced timeline for NDAs. Short-term ...

Epizyme As A Strategic Acquisition For Epigenetic Therapies - Seeking Alpha

Wed, 2019-03-06 08:00
Epizyme As A Strategic Acquisition For Epigenetic Therapies  Seeking Alpha

Epigenetics is a new therapeutic area with strategic implications. Epizyme's stock price has recovered following announced timeline for NDAs. Short-term ...

Epigenetics Market : Latest Innovations, Drivers and Industry Key Events by 2024 - Industry News Today

Wed, 2019-03-06 07:32
Epigenetics Market : Latest Innovations, Drivers and Industry Key Events by 2024  Industry News Today

“Epigenetics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024” report (Sample Copy Here) offers detailed insights on the ...

Riz Ahmed to Star in Bassam Tariq's Debut Feature MUGHAL MOWGLI - Broadway World

Wed, 2019-03-06 07:15
Riz Ahmed to Star in Bassam Tariq's Debut Feature MUGHAL MOWGLI  Broadway World

Emmy®-winning actor and rapper Riz Ahmed is set to play the lead in feature film drama MUGHAL MOWGLI, a story which Ahmed co-wrote and will produce.

Epizyme As A Strategic Acquisition For Epigenetic Therapies - Seeking Alpha

Wed, 2019-03-06 02:00
Epizyme As A Strategic Acquisition For Epigenetic Therapies  Seeking Alpha

Epigenetics is a new therapeutic area with strategic implications. Epizyme's stock price has recovered following announced timeline for NDAs. Short-term ...

Epizyme As A Strategic Acquisition For Epigenetic Therapies - Seeking Alpha

Wed, 2019-03-06 02:00
Epizyme As A Strategic Acquisition For Epigenetic Therapies  Seeking Alpha

Epigenetics is a new therapeutic area with strategic implications. Epizyme's stock price has recovered following announced timeline for NDAs. Short-term ...

Epizyme As A Strategic Acquisition For Epigenetic Therapies - Seeking Alpha

Wed, 2019-03-06 02:00
Epizyme As A Strategic Acquisition For Epigenetic Therapies  Seeking Alpha

Epigenetics is a new therapeutic area with strategic implications. Epizyme's stock price has recovered following announced timeline for NDAs. Short-term ...

Epizyme As A Strategic Acquisition For Epigenetic Therapies - Seeking Alpha

Wed, 2019-03-06 02:00
Epizyme As A Strategic Acquisition For Epigenetic Therapies  Seeking Alpha

Epigenetics is a new therapeutic area with strategic implications. Epizyme's stock price has recovered following announced timeline for NDAs. Short-term ...